XCNQ
GTII
Market cap1.69bUSD
Sep 17, Last price
10.28CAD
1D
-0.96%
1Q
-4.37%
Jan 2017
-30.17%
Name
Green Thumb Industries Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Green Thumb Industries Inc. (GTI) is an American enterprise primarily involved in the production, distribution, and retail of diverse cannabis offerings throughout the United States, serving both medicinal and recreational consumers. Its extensive product catalog features raw cannabis flower, alongside a wide array of processed and packaged goods such as pre-rolls, concentrated extracts, vaporizers, liquid tinctures, edible treats, and topical applications. These items are marketed under notable brands including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM. While GTI primarily supplies its merchandise to independent retail establishments, it also engages in direct-to-consumer sales via its proprietary network of stores. As of April 11, 2022, the company managed and operated 77 retail locations across the U.S. Established in 2014, Green Thumb Industries Inc. maintains its corporate headquarters in Chicago, Illinois.
Key people
Ben Kovler
Chairman of the Board, Chief Executive Officer, Founder · since 2018
Kate Denton
Senior Vice President of Marketing · since 2019
Beth Burk
Chief Legal Officer, Chief Compliance Officer · since 2019
Jennifer Dooley
Chief Strategy Officer
Andrew L. Grossman
Head of Capital Markets
Corporate Secretary · since 2007
Wendy Berger
Director · since 2015
Anthony Valentino Georgiadis
Chief Financial Officer, Director · since 2018
Legal address
250 Howe Street, 20th Floor
Vancouver, BC V6C 3R8
CA
Vancouver, BC V6C 3R8
CA
Headquarters
Suite 2200, HSBC Building, 885 West Georgia Street
Vancouver, BC, ON V6C 3E8
CA
Vancouver, BC, ON V6C 3E8
CA
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2017‑02 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||